Product Recalls in Iowa

Product recalls affecting Iowa — including food, drugs, consumer products, medical devices, and vehicles distributed to Iowa. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,634 recalls have been distributed to Iowa in the last 12 months.

49,990 total recalls
2,634 in last 12 months

Showing 61816200 of 13,371 recalls

DrugNovember 2, 2018· Bound Tree Medical, LLC

Recalled Item: curaplex Epi Safe Administration and Training Kits Recalled by Bound Tree...

The Issue: Labeling Incorrect Instructions: This recall has been initiated because the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 1, 2018· Bound Tree Medical, LLC

Recalled Item: curaplex Epi Safe Administration and Training Kits # 8600-01100. Kit...

The Issue: Labeling: Incorrect or Missing Lot and/or Exp date: vials of epinephrine...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 1, 2018· Bound Tree Medical, LLC

Recalled Item: Curaplex Epi Safe Kit Recalled by Bound Tree Medical, LLC Due to Labeling:...

The Issue: Labeling: Incorrect or missing Lot and/or Exp Date:The Kit is incorrectly...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugOctober 29, 2018· Sciegen Pharmaceuticals Inc

Recalled Item: Westminister Irbesartan Tablets Recalled by Sciegen Pharmaceuticals Inc Due...

The Issue: CGMP Deviations: FDA laboratory testing confirmed presence of an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 29, 2018· Sciegen Pharmaceuticals Inc

Recalled Item: GSMS Irbesartan Tablets Recalled by Sciegen Pharmaceuticals Inc Due to CGMP...

The Issue: CGMP Deviations: FDA laboratory testing confirmed presence of an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 29, 2018· Sciegen Pharmaceuticals Inc

Recalled Item: Westminister Irbesartan Tablets Recalled by Sciegen Pharmaceuticals Inc Due...

The Issue: CGMP Deviations: FDA laboratory testing confirmed presence of an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 29, 2018· Westminster Pharmaceuticals Llc

Recalled Item: Westminster Irbesartan Tablets Recalled by Westminster Pharmaceuticals Llc...

The Issue: CGMP Deviations: FDA laboratory testing confirmed traces of NDEA impurity in...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 29, 2018· Sciegen Pharmaceuticals Inc

Recalled Item: GSMS Irbesartan Tablets Recalled by Sciegen Pharmaceuticals Inc Due to CGMP...

The Issue: CGMP Deviations: FDA laboratory testing confirmed presence of an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 29, 2018· Sciegen Pharmaceuticals Inc

Recalled Item: Westminister Irbesartan Tablets Recalled by Sciegen Pharmaceuticals Inc Due...

The Issue: CGMP Deviations: FDA laboratory testing confirmed presence of an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 29, 2018· Akorn, Inc.

Recalled Item: Clindamycin Phosphate Topical Solution USP Recalled by Akorn, Inc. Due to...

The Issue: Failed Impurities/Degradation Specifications; out of specification results...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugOctober 29, 2018· Sciegen Pharmaceuticals Inc

Recalled Item: GSMS Irbesartan Tablets Recalled by Sciegen Pharmaceuticals Inc Due to CGMP...

The Issue: CGMP Deviations: FDA laboratory testing confirmed presence of an impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 29, 2018· Westminster Pharmaceuticals Llc

Recalled Item: Westminster Irbesartan Tablets Recalled by Westminster Pharmaceuticals Llc...

The Issue: CGMP Deviations: FDA laboratory testing confirmed traces of NDEA impurity in...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 29, 2018· Westminster Pharmaceuticals Llc

Recalled Item: Westminster Irbesartan Tablets Recalled by Westminster Pharmaceuticals Llc...

The Issue: CGMP Deviations: FDA laboratory testing confirmed traces of NDEA impurity in...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 26, 2018· Dr. Reddy's Laboratories, Inc.

Recalled Item: Levetiracetam in 0.54 % Sodium Chloride Injection 1 Recalled by Dr. Reddy's...

The Issue: Labeling: Label Error on Declared Strength; the pre-printed text on the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugOctober 23, 2018· Janssen Pharmaceuticals, Inc.

Recalled Item: Ortho-Novum 1/35 (norethindrone/ethinyl estradiol) Tablets Recalled by...

The Issue: Labeling: Incorrect Instructions; Instructions included for use with the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 23, 2018· Janssen Pharmaceuticals, Inc.

Recalled Item: Ortho-Novum 7/7/7 (norethindrone/ethinyl/estradiol) Tablets Recalled by...

The Issue: Labeling: Incorrect Instructions; Instructions included for use with the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 22, 2018· Boehringer Ingelheim Pharmaceuticals, Inc.

Recalled Item: Catapres .2 (clonidine hydrochloride Recalled by Boehringer Ingelheim...

The Issue: Failed Dissolution Specifications: OOS resultsduring routine stability testing

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 19, 2018· Avella of Deer Valley, Inc. Store 38

Recalled Item: Phenylephrine 30 mg added to NS 250 mL Bag Recalled by Avella of Deer...

The Issue: Lack of assurance of sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 19, 2018· Teva Pharmaceuticals USA

Recalled Item: Metoprolol Succinate Extended Release Tablets Recalled by Teva...

The Issue: Failed dissolution specifications: Out-of-Specification dissolution test...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 19, 2018· Taro Pharmaceuticals U.S.A., Inc.

Recalled Item: children's allergy (cetirizine hydrochloride) Oral Solution Recalled by Taro...

The Issue: Failed Impurities/Degradation Specifications: unknown impurity higher than...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund